Skin & hair

Does Isotretinoin Thin Your Hair?

Save

Hair shedding on isotretinoin is a real, documented side effect, not just internet anecdote — but understanding whether it's the ordinary diffuse thinning the drug can cause, or something else entirely, changes what to do about it. Here's how the two patterns differ, why the shedding happens, and what typically brings hair density back.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does Isotretinoin Actually Cause Hair Thinning?

Isotretinoin can cause hair thinning, and it's a recognized, if uncommon, adverse effect: reviews of the drug's safety profile include hair changes among the mucocutaneous effects that accompany treatment, alongside the more common dry skin, dry lips, and nosebleeds 1. Most people who notice it describe diffuse thinning — hair coming out more than usual when washing or brushing, spread across the scalp rather than in one spot — rather than dramatic, visible bald patches.

Estimates of how many people on isotretinoin notice any hair thinning vary widely across studies, and most reported cases are mild. It's also not universal: plenty of people complete a full course with no noticeable change in hair density at all. When it happens, it tends to show up a few months into treatment rather than in the first weeks, which tracks with how hair growth cycles typically respond to a systemic change.

Why Isotretinoin Affects Hair the Way It Does

Isotretinoin is a retinoid that works throughout the body's keratinizing tissue — skin, lip and nasal lining, and hair follicles share the same basic cell biology the drug affects, which is why its side effects show up in all of those places at once. Hair follicles cycle through growth (anagen), a brief transition (catagen), and rest (telogen), and a new oral medication can push more follicles than usual into that resting phase together — a pattern called telogen effluvium.

When a larger-than-usual share of follicles rest at the same time, more hairs shed together during normal washing and brushing weeks later, which is what registers as diffuse thinning. This mechanism isn't unique to isotretinoin — it's the same process behind hair shedding after a fever, major surgery, rapid weight loss, or childbirth — but isotretinoin is a recognized trigger among the drug-related causes.

Diffuse Thinning vs. Patchy Hair Loss: Telling Them Apart

Distinguishing ordinary isotretinoin-related shedding from a separate hair condition starts with the pattern. Diffuse thinning — more hair than usual coming out over the whole scalp, without a well-defined bald spot — is consistent with telogen effluvium, the pattern isotretinoin is understood to cause. Alopecia areata is different: an autoimmune condition in which the immune system attacks hair follicles directly, typically producing one or more round, well-demarcated bald patches rather than overall thinning 2.

Its course is unpredictable and unrelated to any medication a person happens to be taking. The two can coincide by chance — starting isotretinoin doesn't cause alopecia areata, and a patch appearing during treatment is more likely a coincidence than a drug effect, given how differently the two processes work. Someone who notices a discrete round patch of hair loss, rather than overall thinning, is describing something outside the pattern isotretinoin typically causes, and that distinction is worth mentioning specifically when raising it with a prescriber.

Does the Hair Grow Back After Stopping?

For most people, isotretinoin-related shedding improves once the medication course ends and the hair cycle resets, following the same pattern as other causes of telogen effluvium: new growth resumes, though visibly thicker regrowth can take several months to become noticeable given how slowly hair grows. Because a full isotretinoin course typically runs several months on its own, someone may not fully judge whether density has recovered until close to a year after starting treatment.

A smaller number of people describe thinning that doesn't fully reverse, and disentangling that from ordinary aging-related hair changes, an unrelated diagnosis, or an underlying pattern-hair-loss process that isotretinoin brought to the surface earlier than it might have appeared on its own is genuinely difficult without a clinician looking at the pattern directly. Persistent thinning that continues well past the medication course, rather than gradually improving, is the scenario most worth a follow-up evaluation rather than more waiting.

When Isotretinoin Unmasks Pattern Hair Loss

Isotretinoin doesn't cause androgenetic alopecia — the genetically driven, hormone-sensitive pattern hair loss that runs in families — but in someone already predisposed to it, the stress of a systemic medication and the telogen shedding it triggers can sometimes make an early, previously unnoticed pattern more visible sooner than it otherwise would have appeared. That's an unmasking, not a new condition caused by the drug.

For people who do have androgenetic alopecia, whether isotretinoin played any role in revealing it or not, a systematic review and meta-analysis found that minoxidil and finasteride both promote hair growth in men, and that minoxidil is effective in women with the condition as well 3. That's a separate treatment conversation from managing isotretinoin's temporary shedding, and it typically involves a dermatologist assessing whether the pattern looks like classic androgenetic alopecia — thinning concentrated at the crown or temples rather than diffusely across the whole scalp — before recommending a specific option.

What to Do If You Notice Hair Shedding on Isotretinoin

Isotretinoin is dispensed only through the FDA's iPLEDGE program, which requires monthly visits with a prescriber for the full course of treatment 4 — visits that double as a natural checkpoint for reporting any hair changes rather than waiting until the course ends to bring it up. Describing the pattern clearly (diffuse versus patchy, when it started, whether it's still increasing or has leveled off) gives a prescriber more to work with than a general "my hair is falling out."

Mild diffuse shedding that stays mild is usually managed by simply continuing treatment and monitoring, since isotretinoin's benefit for severe or scarring acne often outweighs temporary cosmetic hair changes for most people who need it. More significant shedding, a patchy rather than diffuse pattern, or thinning accompanied by other new symptoms is worth a more specific conversation about whether to continue at the same dose, adjust it, or investigate another cause.

Common questions

Reported rates vary widely across studies, and most documented cases are mild diffuse shedding rather than dramatic loss. It's a recognized but not universal effect — many people complete a full course without noticing any change in hair density, and among those who do notice thinning, most describe it as subtle rather than severe.

Adverse effects from isotretinoin, including mucocutaneous ones, are generally understood to track with cumulative dose and duration, though individual sensitivity varies a great deal and dose isn't a precise predictor for any one person. A prescriber adjusting dose based on both acne response and side-effect tolerance, hair changes included, is standard practice rather than a sign something has gone wrong.

There's no strong evidence that biotin or other over-the-counter hair supplements prevent or reduce isotretinoin-related shedding, since the mechanism is a temporary shift in hair-cycle timing rather than a nutrient deficiency. Biotin supplementation can also interfere with certain lab tests, including some thyroid panels, which is worth mentioning to a prescriber before starting one during isotretinoin treatment.

That's a decision for the prescribing clinician, weighing how significant the shedding is against how the acne is responding and how severe it was to begin with. Mild diffuse shedding often doesn't require stopping treatment, since it tends to improve after the course ends regardless, while more significant or patchy hair loss is more likely to prompt a closer look or a change in plan.

The underlying telogen-effluvium mechanism isn't specific to sex, but women are more likely to already be monitoring hair density closely and may notice diffuse shedding sooner. Women are also more likely to have an underlying pattern-hair-loss process unmasked during treatment, which is one reason a clinician evaluating hair changes may ask about family history and hormonal patterns as part of the picture.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When Hair Loss on Isotretinoin Needs a Closer Look

  • —A round, well-demarcated bald patch rather than overall thinning, which points toward alopecia areata rather than a medication effect
  • —Hair loss accompanied by unexplained fatigue, weight change, or other new symptoms that could suggest a thyroid or other systemic cause
  • —Shedding that keeps increasing rather than leveling off, or that hasn't started improving several months after finishing isotretinoin

This article explains a recognized medication side effect in general terms; it isn't a substitute for a dermatologist's evaluation of a specific pattern of hair loss, especially while on isotretinoin or another prescription medication.

References

  1. 1.Costa CS, Bagatin E, Martimbianco ALC, et al. (2018). Oral isotretinoin for acne. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD009435.pub2Cochrane systematic review characterizing isotretinoin's mucocutaneous and other adverse effects, cited to support that hair changes are among the recognized side effects of oral isotretinoin treatment for acne.
  2. 2.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Alopecia Areata. NIH / NIAMS. link ✓Institutional definitional overview of alopecia areata as an autoimmune, typically patchy hair-loss condition, cited to distinguish it from the diffuse telogen-effluvium pattern isotretinoin can cause.
  3. 3.Adil A, Godwin M (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. PMID 28396101 ✓Systematic review and meta-analysis supporting that minoxidil and finasteride promote hair growth in androgenetic alopecia, cited for the separate treatment conversation relevant when isotretinoin unmasks an underlying pattern-hair-loss process.
  4. 4.U.S. Food and Drug Administration (2023). iPLEDGE Risk Evaluation and Mitigation Strategy (REMS). U.S. Food and Drug Administration. link ✓FDA description of the iPLEDGE REMS program's mandatory monthly prescriber visits, cited to support that isotretinoin treatment includes regular monitoring checkpoints where side effects like hair changes can be reported.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library